SEC Insider Transactions from Mosbrooker Eric.

Last updated: 2026-03-14 11:53 UTC | Total transactions: 19

Eric Mosbrooker, Chief Commercial Officer of Avidity Biosciences ($RNA), sold about $6.4 million worth of company shares in four open market transactions over the past year. His most recent sale occurred on October 3, 2025. These sales rank him 1,618th among nearly 12,000 insiders by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. Mosbrooker made no open market purchases in this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 27, 2026 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer D Stock Option (Right to Buy) 50000 $0.00 0.0000 150,675,742 100.00% 0.03%
Feb. 27, 2026 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer D Stock Option (Right to Buy) 177188 $0.00 0.0000 150,675,742 100.00% 0.12%
Feb. 27, 2026 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer D Common Stock 79413 $0.00 0.0000 150,675,742 100.00% 0.05%
Dec. 17, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer A Common Stock 72000 $0.00 127,000.0000 150,675,742 130.91% 0.05%
Dec. 17, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer F Common Stock 11426 $71.87 79,010.0000 150,675,742 12.63% 0.01%
Dec. 17, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer F Common Stock 36564 $71.87 90,436.0000 150,675,742 28.79% 0.02%
Oct. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Common Stock 6562 $9.05 61,562.0000 120,212,301 11.93% 0.01%
Oct. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer S Common Stock 6562 $45.38 55,000.0000 120,212,301 10.66% 0.01%
Oct. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Stock Option (Right to Buy) 6562 $0.00 177,188.0000 120,212,301 3.57% 0.01%
Sept. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Stock Option (Right to Buy) 6563 $0.00 183,750.0000 120,212,301 3.45% 0.01%
Sept. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Common Stock 6563 $9.05 61,563.0000 120,212,301 11.93% 0.01%
Sept. 3, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer S Common Stock 6563 $47.07 55,000.0000 120,212,301 10.66% 0.01%
Aug. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Common Stock 124687 $9.05 185,807.0000 120,212,301 204.00% 0.10%
Aug. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer S Common Stock 6120 $44.06 55,000.0000 120,212,301 10.01% 0.01%
Aug. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer S Common Stock 124687 $44.06 61,120.0000 120,212,301 67.11% 0.10%
Aug. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer M Stock Option (Right to Buy) 124687 $0.00 190,313.0000 120,212,301 39.58% 0.10%
Jan. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer A Stock Option (Right to Buy) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
Jan. 6, 2025 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Chief Commercial Officer A Common Stock 25000 $0.00 61,120.0000 0 69.21% 0.00%
June 15, 2023 Avidity Biosciences, Inc. $RNAM Mosbrooker Eric Director A Stock Option (Right to Buy) 22000 $0.00 22,000.0000 0 9999.99% 0.00%